These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 24342765

  • 1. The debated role for thiopurines in Crohn's disease.
    Herrlinger KR, Stange EF.
    J Crohns Colitis; 2014 Feb; 8(2):172-4. PubMed ID: 24342765
    [Abstract] [Full Text] [Related]

  • 2. Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.
    Axelrad JE, Roy A, Lawlor G, Korelitz B, Lichtiger S.
    World J Gastroenterol; 2016 Dec 14; 22(46):10103-10117. PubMed ID: 28028358
    [Abstract] [Full Text] [Related]

  • 3. [Role of thiopurine agents in ulcerative colitis].
    Chaparro M, Gisbert JP.
    Gastroenterol Hepatol; 2011 Dec 14; 34 Suppl 3():30-5. PubMed ID: 25443224
    [Abstract] [Full Text] [Related]

  • 4. 6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease.
    Korelitz BI, Present DH.
    J Crohns Colitis; 2014 Aug 14; 8(8):735-8. PubMed ID: 24462321
    [Abstract] [Full Text] [Related]

  • 5. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S.
    Dtsch Med Wochenschr; 2013 Sep 14; 138(38):1877. PubMed ID: 24022448
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
    Markowitz JF.
    Rev Gastroenterol Disord; 2003 Sep 14; 3 Suppl 1():S23-9. PubMed ID: 12684586
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunosuppressants and Crohn's disease.
    Goldstein F.
    Gastroenterology; 1972 May 14; 62(5):1101-2. PubMed ID: 5029074
    [No Abstract] [Full Text] [Related]

  • 12. Is thiopurine therapy in ulcerative colitis as effective as in Crohn's disease?
    Ghosh S, Chaudhary R, Carpani M, Playford RJ.
    Gut; 2006 Jan 14; 55(1):6-8. PubMed ID: 16344570
    [Abstract] [Full Text] [Related]

  • 13. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.
    Peyrin-Biroulet L, Deltenre P, Ardizzone S, D'Haens G, Hanauer SB, Herfarth H, Lémann M, Colombel JF.
    Am J Gastroenterol; 2009 Aug 14; 104(8):2089-96. PubMed ID: 19568226
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [When is drug therapy with azathioprine indicated in Crohn's disease?].
    Rogler G, Herfarth H.
    Dtsch Med Wochenschr; 2002 May 31; 127(22):1213-4. PubMed ID: 12035120
    [No Abstract] [Full Text] [Related]

  • 16. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec 31; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS, Zlatanic J, Korelitz BI, Gleim GW.
    Am J Gastroenterol; 1999 Nov 31; 94(11):3254-7. PubMed ID: 10566725
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.